the limitations of immunotherapy with car t-cells
Published 5 years ago • 659 plays • Length 3:49Download video MP4
Download video MP3
Similar videos
-
1:20
limitations of car t-cell therapy for dlbcl
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
4:21
an insight into the changing role of transplantation for myeloma & lymphoma in the era of car-t
-
2:30
the future of car t-cell therapy
-
2:22
car t-cell immunotherapy: current status and perspectives
-
1:35
key mechanisms of resistance to car t-cell therapy
-
4:43
immunotherapy & car t cells: part 1
-
4:45
what is lymphodepleting chemotherapy?
-
14:48
car t cell therapy quick guide
-
33:15
morning medical update - car-t cell immunotherapy
-
2:56
the future landscape of car t-cell therapy
-
3:07
car t-cell therapy: cancer immunotherapy beyond checkpoint inhibitors
-
1:16
challenges of car t-cells in solid tumors
-
2:52
current immunotherapeutic approaches in dlbcl: the value of car-t cells and bispecific antibodies
-
4:47
cd19 car t-cells for adults
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:55
updates in immunotherapy for multiple myeloma: bites & novel targets
-
1:25
the role of car-t therapy and hsct in autoimmune disorders
-
4:10
overcoming the limits: bringing car t-cell therapy to the masses
-
1:37
patient education in car t-cell therapy
-
5:40
current concepts and future developments in t-cell-based immunotherapy of aml